岡山大学大学院医歯薬学総合研究科呼吸器・乳腺内分泌外科(第2外科)は大正12年に開講し、現在同門会員723名を擁する大外科学教室です。とくに関連病院(各地の基幹病院)に関しては中四国随一の質および数を誇っています。砂田輝武、寺本滋前教授時代は心臓血管外科とともに呼吸器、消化器、内分泌、輸液と幅広い分野で学会をリードしてきた実績があります。平成2年4月に心臓血管外科が独立しましたが、消化器、呼吸器、内分泌、輸液の分野は呼吸器・乳腺内分泌外科に引き継がれており、心臓血管外科は現在も兄弟科としてお互いに協力しあって診療・研究を行っています。
詳しくはこちら
当科の歴史
1923年(大正12年)11月に西川義英教授が欧米留学より帰国し、第二外科学教室を創設してから実に80年以上の歴史を持つ「岡山大学大学院医歯薬学総合研究科呼吸器・乳腺内分泌外科」の歴代の教授と教室の沿革についてご紹介いたします。
詳しくはこちら
教職員紹介
自由と活気のある若さあふれる教室である「呼吸器・乳腺内分泌外科教室」の教職員を紹介いたします。「鬼手仏心」:外科医は残酷なほど大胆に手術するが、それは患者を治そうとするやさしい心によるものだ、ということを銘として切磋琢磨しながらも仕事を離れると大変和気あいあいとした雰囲気で教室員一同みんな仲がよいのが特徴です。
詳しくはこちら
最近の業績
2023年以降
- Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia., J Thorac Oncol, 18(4), 436, 446, 2023, Mitsudomi T, Tan D, Yang J, et al.
- Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer., J Clin Oncol, 41(34), 5242, 5246, 2023, Kenmotsu H, Yamamoto N, Misumi T, et al.
- A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection., PLoS One, 18(10), e0287501, , 2023, Ichihara E, Hasegawa K, Kudo K, et al.
- Connective tissue mast cells store and release noradrenaline., J Physiol Sci, 73(1), 24, , 2023, Otani Y, Yoshikawa S, Nagao K, et al.
- Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022., Surg Today, 53(10), 1188, 1198, 2023, Oishi H, Okada Y, Sato M, et al.
- Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201., PLoS One, 18(5), e0285273, , 2023, Yamamoto H, Soh J, Okumura N, et al.
- EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery., Ann Surg Oncol, 30(11), 6697, 6702, 2023, Fujiwara T, Shien K, Matsuura M, et al.
- Ⅲ. The Role of Comprehensive Genomic Profiling in Sarcoma., Gan To Kagaku Ryoho, 50(3), 314, 320, 2023, Nakata E, Fujiwara T, Kunisada T, et al.
- Perioperative Management for Patients with Metabolic and Endocrine Disorders., Kyobu Geka, 76(10), 844, 848, 2023, Suzawa K, Toyooka S, , et al.
- Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer., Breast Cancer, 30(5), 856, 868, 2023, Suzuki Y, Iwamoto T, Uno M, et al.
- ASO Author Reflections: Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio are Prognostic Factors in Pulmonary Metastases from Uterine Leiomyosarcoma., Ann Surg Oncol, 30(13), 8757, 8758, 2023, Matsuda N, Yamamoto H, Habu T, et al.
- Author Correction: Identification of genetic loci associated with renal dysfunction after lung transplantation using an ethnic-specific single-nucleotide polymorphism array., Sci Rep, 13(1), 16721, , 2023, Tomioka Y, Sugimoto S, Yamamoto H, et al.
- The consecutive impact of COVID-19 on thoracic surgical procedures in Japan: an analysis of data from the National Clinical Database., Surg Today, , , , 2023, Sato Y, Yamamoto H, Ikeda N, et al.
- LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells., Front Oncol, 13, 1142886, , 2023, Hirabayashi D, Yamamoto K, Maruyama A, et al.
- Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2., Front Oncol, 13, 1142907, , 2023, Komalasari N, Tomonobu N, Kinoshita R, et al.
- Long-term outcomes following surgical treatment for thymic epithelial tumor in Japan and an analysis of prognostic factors based on the Japanese Association for Research on the Thymus nationwide database., Surg Today, 53(11), 1247, 1259, 2023, Okumura M, Yoshino I, Funaki S, et al.
- Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery., Breast Cancer, 30(1), 56, 67, 2023, Zhu Y, Iwamoto T, Kajiwara Y, et al.
- 肺合併症を減らすための周術期対策, 臨床雑誌外科, 85, 557, 564, 2023, 杉本誠一郎, 豊岡伸一, , et al.
- The impact of prognostic nutrition index on the waitlist mortality of lung transplantation., Gen Thorac Cardiovasc Surg, 71(5), 306, 312, 2023, Matsubara K, Otani S, Yamamoto H , et al.
- Donor's long-term quality of life following living-donor lobar lung transplantation., Clin Transplant, 37(4), e14927, , 2023, Fujii K, Tanaka S, Ishihara M, et al.
- Diagnostic value of circulating microRNA-21 in chronic lung allograft dysfunction after bilateral cadaveric and living-donor lobar lung transplantation., Heliyon, 9(4), e14903, , 2023, Shiotani T, Sugimoto S, Tomioka Y, et al.
- S100A8/A9 as a prognostic biomarker in lung transplantation., Clin Transplant, 37(9), e15006, , 2023, Nakata K, Okazaki M, Kawana S, et al.
- One-year change in the health status predicts the subsequent hospitalization and mortality in patients waitlisted for lung transplantation in Japan, Respir Investig, 61, 478, 484, 2023, Ikeda M, Wakatsuki Y, Oga T, et al.
- Pulmonary alveolar proteinosis after lung transplantation: Two case reports and literature review., Respirol Case Rep, 11(6), e01160, , 2023, Kawana S, Miyoshi K, Tanaka S, et al.
- Identification of genetic loci associated with renal dysfunction after lung transplantation using an ethnic-specific single-nucleotide polymorphism array., Sci Rep, 13(1), 8912, , 2023, Tomioka Y, Sugimoto S, Yamamoto H, et al.
- Elderly lung transplant recipients show acceptable long-term outcomes for lung transplantation: A propensity score-matched analysis., Surg Today, 53(11), 1286, 1293, 2023, Tomioka Y, Tanaka S, Otani S, et al.
- Endobronchial Metastasis with Bloody Sputum 20 Years after Complete Resection of type A Non-Invasive Thymoma., Acta Med Okayama, 77(3), 331, 334, 2023, Watanabe M, Yamamoto H, Miyoshi K, et al.
- Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation., Clin Transplant, 37(11), e15077, , 2023, Kubo Y, Sugimoto S, Shiotani T, et al.
- Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma., Ann Surg Oncol, 30(13), 8727, 8734, 2023, Matsuda N, Yamamoto H, Habu T, et al.
- Successful management of temporary veno-venous extracorporeal membrane oxygenation for a pediatric lung transplant recipient with bronchiolitis obliterans syndrome awaiting lung re-transplantation: a case report., Surg Case Rep, 9(1), 163, , 2023, Tomioka Y, Miyoshi K, Tanaka S, et al.
- Use of the index of pulmonary vascular disease for predicting long-term outcome of pulmonary arterial hypertension associated with congenital heart disease., Front Cardiovasc Med, 10, 1212882, , 2023, Chida-Nagai A, Masaki N, Maeda K, et al.
- ASO Visual Abstract: Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine Leiomyosarcoma, Ann Surg Oncol, 30, 8762, 8763, 2023, Matsuda N, Yamamoto H, Habu T, et al.
- Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer., J Mol Med (Berl), 101(12), 1603, 1614, 2023, Takatsu F, Suzawa K, Tomida S, et al.
- Long-term management and outcome of lung transplantation in Japan., J Thorac Dis, 15(9), 5182, 5194, 2023, Sugimoto S, Matsubara K, Tanaka S, et al.
- Successful Living-donor Lobar Lung Transplantation With BK Virus-related Hemorrhagic Cystitis Throughout the Perioperative Period., Transplant Direct, 10(1), e1556, , 2023, Tomioka Y, Otani S, Tanaka S, et al.
- Surgical outcome of ipsilateral anatomical resection for lung cancer after pulmonary lobectomy., Eur J Cardiothorac Surg, 63(3), 48, , 2023, Okazaki M, Suzawa K, Shien K, et al.
- ASO Author Reflections: Prognostic Impact of the Primary Tumor Resection for Lung Cancer Patients Diagnosed with Pleural Dissemination in the Perioperative Period-Importance of Biomarker-Based Treatment Decision Making., Ann Surg Oncol, 30(11), 6703, 6704, 2023, Shien K, Fujiwara T, Toyooka S, et al.
- Immunomodulation of the donor lung with CRISPR-mediated activation of IL-10 expression, The Journal of Heart and Lung Transplantation, 42(10), 1363, 1377, 2023, Mesaki K, Juvet S, Yeung J, et al.
- A Novel Tissue Preservation and Transport Solution as a Substitute for Formalin, Laboratory Investigation, 103(9), 100198, , 2023, Vucevic D, Seidman M, Mesaki K, et al.
- Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes the generation of the whole lung., Elife, 12, e86105, , 2023, Miura A, Sarmah H, Tanaka J, et al.
- Ex vivo lung perfusion moderates gene expression differences between cardiac death and brain death donor lungs., JHLT OPEN, 3, 100027, , 2023, Allen J, Sage A, Yamamoto H, et al.
- Metastasis-directed therapy for oligometastases in breast cancer., Jpn J Clin Oncol, 53(10), 893, 898, 2023, Ishiba T, Nishibuchi I, Hara F, et al.
- Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer., Breast Cancer Res Treat, 202(3), 473, 483, 2023, Sasada S, Kondo N, Hashimoto H, et al.
- Current status and challenges of breast cancer prevention~DNA methylation would lead to groundbreaking progress in breast cancer prevention~., Genes Environ., 45(1), 35, , 2023, Tsukioki T, Khan SA, Shien T, et al.
- Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer., Breast Cancer, 30(5), 856, 868, 2023, Suzuki Y, Iwamoto T, Uno M, et al.
- ASO Author Reflections: Is Nipple-Areolar Recurrence After Nipple-Sparing Mastectomy Simply a "Cosmetic Failure"?, Ann Surg Oncol, 30(3), 1687, 1688, 2023, Ishitobi M, Shien T, , et al.
- Safety and Efficacy of a Well-Fitting Brassiere after Breast Reconstruction: A Qualitative Study., Acta Med Okayama, 77(1), 11, 19, 2023, Watanabe S, Saiga M, Motoki T, et al.
- Preferences Regarding Breast Surgery Omission Among Patients With Breast Cancer Who Receive Neoadjuvant Chemotherapy., In Vivo, 37(2), 794, 800, 2023, Nakamura K, Ishitobi M, Oshiro C, et al.
- Impact of Immediate Breast Reconstruction on Survival of Breast Cancer Patients: A Single-Center Observational Study., Acta Med Okayama, 77(3), 281, 290, 2023, Mukai Y, Taira N, Kajiwara Y, et al.
- Physicians' perception about the impact of breast reconstruction on patient prognosis: a survey in Japan., Breast Cancer, 30(2), 302, 308, 2023, Yamakado R, Ishitobi M, Kondo N, et al.
- An observational study of the impact of immediate breast reconstruction on perioperative inflammatory cytokines., Surg Today, 53(11), 1305, 1316, 2023, Mukai Y, Taira N, Kitaguchi Y, et al.
- ASO Author Reflections: Long Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction., Ann Surg Oncol, 30(11), 6541, 6542, 2023, Ogiya A, Nagura N, Shimo A, et al.
- The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition., Breast Cancer, 31(1), 1, 7, 2023, Sakai T, Kutomi G, Shien T, et al.
- ASO Visual Abstract: Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction-A Retrospective, Multi-institutional Study of 4153 Cases., Ann Surg Oncol, 30(11), 6543, 6544, 2023, Ogiya A, Nagura N, Shimo A, et al.
- Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services., JMA J, 6(4), 505, 512, 2023, Takayama S, Kinoshita T, Shiino S, et al.
- Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences., Ann Surg Oncol, 30(3), 1678, 1686, 2023, Yamaguchi A, Ishitobi M, Nagura N, et al.
- Long-Term Outcomes of Breast Cancer Patients with Local Recurrence After Mastectomy Undergoing Immediate Breast Reconstruction: A Retrospective Multi-institutional Study of 4153 Cases., Ann Surg Oncol, 30(11), 6532, 6540, 2023, Ogiya A, Nagura N, Shimo A, et al.
- Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple negative advanced breast cancer: a retrospective multicenter observational study., Clin Exp Med, 23(8), 5129, 5138, 2023, Nakamoto S, Shien T, Itoh M, et al.
- Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery., Breast Cancer, 30(1), 56, 67, 2023, Zhu Y, Iwamoto T, Kajiwara Y, et al.
- Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study., Breast Cancer, 31(1), 75, 83, 2023, Yoshida M, Yoshimura RI, Notake R, et al.
- 医療者が考える医療経済の落とし穴:医療者が医療資源の配分について論じる前に知って欲しいこと, 臨床薬理, 54, 63, 70, 2023, 山本圭一郎, 水谷友紀, 岩谷胤生, et al.
- Patient-Reported Outcome and Quality of Life Research Policy: Japan Clinical Oncology Group (JCOG) Policy., Japanese Journal of Clinical Oncology. , 53, 195, 202, 2023, Ishiki H, Kikawa Y, Terada M, et al.
- Optimization of smartphone psychotherapy for depression and anxiety among patients with cancer using the multiphase optimization strategy (MOST) framework and decentralized clinical trial system (Smartphone Intervention to LEssen depression/Anxiety and GAIN resilience: SMILE AGAIN project): A protocol for a randomized controlled trial., Trials , 24, 344, , 2023, Uchida M, Furukawa T, Yamaguchi T. Imai F, et al.
- Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician Perspectives. , Breast Cancer , 30, 820, 830, 2023, Saeki S, Iwatani T, Kitano A, et al.
- Surgical site infections in thyroid and parathyroid surgery in Japan: an analysis of the Japan Nosocomial Infections Surveillance database from 2013 to 2020. , International Wound Journal , 20, 1874, 1881, 2023, Iwatani T, Saito S., , et al.
2022
-
Long-term outcomes of living-donor lobar lung transplantation,
J Thorac Cardiovasc Surg,164(2),440,448,2022,Sugimoto S,Date H,Miyoshi K, et al.
-
Robotic Mediastinal Tumor Resections: Position and Port Placement,J Pers
Med,12(8),1195,2022,Okazaki M,Shien K,Suzawa K, et al.
-
Paediatric lung transplantation: the impact of age on the survival,Surg
Today,52(11),1540,1550,2022,Otani S,Yamamoto H,Tanaka S,
et al.
-
Functional Blockage of S100A8/A9 Ameliorates Ischemia-Reperfusion Injury in the Lung
,Bioengineering (Basel),10,673,2022,Nakata K ,Okazaki M ,Sakaue T, et al.
-
[Chronic Lung Allograft Dysfunction after Living-donor Lobar Lung Transplantation],Kyobu
Geka,75(4),297,301,2022,
Sugimoto S,Tanaka S,Miyoshi K, et al.
-
Lung Transplantation for Bronchiectasis Due to Hyperimmunoglobulin E Syndrome,Ann Thorac
Surg,113(4),e251,e253,2022,
Shimizu D,Otani S,Sugimoto S, et al.
-
Role of surgery in a novel multimodal therapeutic approach to complete cure of advanced
lung cancer: current and future perspectives,
Surg Today,52(1),1,11,2022,Yamane M,Toyooka S
-
The impact of prognostic nutrition index on the waitlist mortality of lung
transplantation,Gen Thorac Cardiovasc Surg,2022,
Matsubara K,Otani S,Yamamoto H, et al.
-
Acute Pulmonary Edema Due to Arteriovenous Shunt Placement After Lung
Transplantation,Ann Thorac Surg,114(4),e245,e247,2022,Shimizu D,Miyoshi K,Sugimoto S, et
al.
-
Inhibiting S100A8/A9 attenuates airway obstruction in a mouse model of heterotopic
tracheal transplantation,Biochem Biophys Res Commun,629,86,94,2022,Shimizu D,Okazaki
M,Sugimoto S, et al.
-
Completely Video-assisted Thoracoscopic Lobectomy for Congenital Lobar Emphysema in a
Young Adult,Acta Med Okayama ,76(1),89,92,2022,Ryuko T,Yamamoto H,Sugimoto S, et al.
-
Clinical Features of Patients With Second Primary Lung Cancer After Head and Neck
Cancer,Ann Thorac Surg,S0003-4975(22),00705-6,2022,Takatsu F,Suzawa K,Okazaki M, et al.
-
13 Limited resection for stage IA radiologically invasive lung cancer: a real-world
nationwide database study,Eur J Cardiothorac Surg,62(1),342,2022,Soh J,Toyooka
S,Shintani Y, et al.
-
Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung
metastases from retroperitoneal sarcoma,World J Surg Oncol,20(1),114,2022,Takatsu
F,Yamamoto H,Tomioka Y, et al.
-
Gene Expression Profiling between Patient Groups with High and Low Ki67 Levels after
Short-term Preoperative Aromatase Inhibitor Treatment for Breast Cancer,Acta Med
Okayama,76(4),399,408,2022,Kajiwara Y, Iwamoto T,Zhu Y, et al.
-
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy:
Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week
Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients,Acta Med
Okayama,76(6),661,671,2022, Abe Y,Taira N,Kashiwabara K, et al.
-
Lung recruitment after cardiac arrest during procurement of atelectatic donor lungs is a
protective measure in lung transplantation,J Thorac Dis,14(8),2802,2811,2022,Niman
E,Miyoshi K,Shiotani T, et al.
-
SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and
as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor
Inhibitors,JCO Precis Oncol,6,e2200088,2022,Sato H,Kubota D,Qiao H, et al.
-
One-step nucleic acid amplification for intraoperative diagnosis of lymph node
metastasis in lung cancer patients: a single-center prospective study,Necroptosis
triggers spatially restricted neutrophil-mediated vascular damage during lung ischemia
reperfusion injury,12(1),7297,2022,Namba K,Suzawa K,Shien K, et al.
-
Emphysematous changes and lower levels of plasma irisin are associated with
bronchiolitis obliterans syndrome after bilateral living-donor lobar lung
transplantation,Surg Today,52(2),294,305,2022,Shiotani T,Sugimoto S,Yamamoto H, et al.
-
Circulating anti-human leukocyte antigen IgM antibodies as a potential early predictor
of allograft rejection and a negative clinical outcome after lung transplantation,Surg
Today,52(1),52,60,2022,Miyahara K,Miyoshi K,Kurosaki T, et al.
-
Effect of preoperative long-term use of corticosteroids on the development of
post-transplant lymphoproliferative disorders after lung transplantation: a
single-center experience in Japan,Surg Today,52(4),697,704,2022,Shimizu D,Otani
S,Sugimoto S, et al.
-
生体肺移植後の慢性移植肺機能不全(CLAD),胸部外科,75,297,301,2022,杉本誠一郎,田中 真,三好健太郎,
et al.
-
Robotic Mediastinal Tumor Resections: Position and Port Placement,J Pers
Med,12,1195,2022,Okazaki M, Shien K, Suzawa K, et al.
-
境界領域の臨床解剖 上縦隔 ,耳鼻咽喉科,2,113,119,2022,岡﨑幹生,豊岡伸一
-
岡山大学呼吸器・乳腺内分泌外科学教室における人材育成,胸部外科,75,1122,1124,2022,三好健太郎,岡﨑幹生,豊岡伸一
-
Evaluation of Uncontrolled Donation After Circulatory Death Lungs by Conventional In
Situ Effluent Gas Analysis and Ex Vivo Lung Perfusion, Archivos de Bronconeumología
,58,569,571,2022, Tanaka S, Lucas Hoyos Mejía, Alejandra Romero Román,etal, et al.
-
無症候性多発性骨髄腫を合併した肋骨形質細胞腫の一切除例,呼吸器外科学会雑誌,36,180,186,2022,川名伸一,上野剛,末久弘,
et al.
2021
-
Shimizu D, Otani S, Sugimoto S, et al. Effect of preoperative
long-term use of
corticosteroids on the development of post-transplant lymphoproliferative disorders
after lung transplantation: a single-center experience in Japan. Surg
Today. 2021 Oct
25. doi: 10.1007/s00595-021-02390-7.
-
Tomioka Y, Otani S, Tanaka S, et al. Lung transplantation for
idiopathic multicentric
Castleman disease: potential efficacy and tolerability of a humanized
anti-interleukin-6
receptor monoclonal antibody. Surg Case Rep. 2021 Sep 17;7(1):209. doi:
10.1186/s40792-021-01297-2.
-
Nakata K, Okazaki M, Shimizu D, et al. Protective effects of
anti-HMGB1 monoclonal
antibody on lung ischemia reperfusion injury in mice. Biochem Biophys Res
Commun. 2021
Oct 8;573:164-170. doi: 10.1016/j.bbrc.2021.08.015.
-
Okazaki M, Suzawa K, Shien K, et al. Robot-assisted
thoracoscopic lobectomy for severe
incomplete interlober fissure. J Surg Case Rep. 2021 Aug
14;2021(8):rjab336. doi:
10.1093/jscr/rjab336.
-
Shiotani T, Sugimoto S, Yamamoto H, et al. Emphysematous
changes and lower levels of
plasma irisin are associated with bronchiolitis obliterans syndrome after bilateral
living-donor lobar lung transplantation. Surg Today. 2021 Jul 12. doi:
10.1007/s00595-021-02339-w.
-
Shimizu D, Otani S, Sugimoto S, et al. Lung transplantation
for bronchiectasis due to
hyper-immunoglobulin E syndrome. Ann Thorac Surg. 2021 Jul
2:S0003-4975(21)01094-8. doi:
10.1016/j.athoracsur.2021.05.088.
-
Miura A, Yamada D, Nakamura M, et al. Oncogenic potential of
human pluripotent stem
cell-derived lung organoids with HER2 overexpression. Int J Cancer. 2021
Oct
15;149(8):1593-1604. doi: 10.1002/ijc.33713.
-
Kurosaki T, Oto T, Otani S, et al. Hybrid Lung
Transplantation" Combining Living Donor
and Cadaveric Lung Transplants: Report of 2 Cases. Transplant Proc. 2021
Jul-Aug;53(6):2004-2007. doi: 10.1016/j.transproceed.2021.04.019.
-
Okazaki M, Takigawa T, Suzawa K, Toyooka S. Robot-assisted
intrathoracic procedure for
dumbbell tumour in the prone position. Interact Cardiovasc Thorac Surg.
2021 Oct
4;33(4):643-645. doi: 10.1093/icvts/ivab117.
-
Miyahara K, Miyoshi K, Kurosaki T, et al. Circulating
anti-human leukocyte antigen IgM
antibodies as a potential early predictor of allograft rejection and a negative
clinical
outcome after lung transplantation. Surg Today. 2021 May 7. doi:
10.1007/s00595-021-02293-7.
-
Yamane M, Toyooka S. Role of surgery in a novel multimodal
therapeutic approach to
complete cure of advanced lung cancer: current and future perspectives.
Surg Today. 2021
Mar 18. doi: 10.1007/s00595-021-02228-2.
-
Shiotani T, Yamamoto H, Katsube R, et al. Successful
Bronchoscopic Treatment for
Postoperative Bronchopleural Fistula Using N-butyl-2-cyanoacrylate (NBCA): Report of
a
Post-completion Pneumonectomy Case with a History of Induction Chemoradiotherapy
Followed by Bilobectomy for Advanced Lung Cancer. Acta Med Okayama. 2021
Feb;75(1):91-94. doi: 10.18926/AMO/61440.
-
Shiotani T, Sugimoto S, Araki K, et al. Long-term Follow-up
of Living-Donor Kidney
Transplantation after Cadaveric Lung Transplantation. Acta Med Okayama.
2021
Feb;75(1):87-89. doi: 10.18926/AMO/61439.
-
Tsudaka S, Yamamoto H, Sato H, Toyooka S. ASO Author
Reflections: Impact of the
Postoperative Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small Cell Lung
Cancer Treated with Induction Chemoradiotherapy Followed by Surgery. Ann
Surg Oncol.
2021 Sep;28(9):4891-4892. doi: 10.1245/s10434-021-09699-0.
-
Tsudaka S, Yamamoto H, Sato H, et al. Prognostic Significance
of
Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer
Treated
with Trimodality Therapy. Ann Surg Oncol. 2021 Sep;28(9):4880-4890. doi:
10.1245/s10434-021-09690-9.
-
Yamamoto H, Sugimoto S, Soh J, et al. The prognostic
nutritional index is correlated
negatively with the lung allocation score and predicts survival after both cadaveric
and
living-donor lobar lung transplantation. Surg Today. 2021
Oct;51(10):1610-1618. doi:
10.1007/s00595-021-02244-2.
-
Miura A, Yamamoto H, Sato H, et al. The prognostic impact of
sarcopenia on elderly
patients undergoing pulmonary resection for non-small cell lung cancer.
Surg Today. 2021
Jul;51(7):1203-1211. doi: 10.1007/s00595-020-02221-1.
-
Nakata K, Sugimoto S, Yamane M, Toyooka S. Staged surgery for
empyema and lung gangrene
caused by pseudoaneurysm after radiofrequency ablation. Interact Cardiovasc
Thorac Surg.
2021 May 10;32(5):831-833. doi: 10.1093/icvts/ivaa331.
-
Yamamoto H, Yamamoto H, Soh J, et al. A Simple Prognostic
Benefit Scoring System for
Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
Ann Surg
Oncol. 2021 Jul;28(7):3884-3890. doi: 10.1245/s10434-020-09272-1.
-
Kawada K, Taira N, Mizoo T, et al. Relationships of physical
and breast cancer
phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and
rs3803662) associated with breast cancer risk in Japanese women. Breast
Cancer. 2021
Mar;28(2):478-487. doi: 10.1007/s12282-020-01185-x.
-
Araki K, Kinoshita R, Tomonobu N, et al. The heterodimer
S100A8/A9 is a potent
therapeutic target for idiopathic pulmonary fibrosis. J Mol Med (Berl).
2021
Jan;99(1):131-145. doi: 10.1007/s00109-020-02001-x.
-
Yamamoto H, Otani S, Miyoshi K, et al. Long-term clinical
follow-up after lung
transplantation in patient with scoliosis: a case report. Gen Thorac
Cardiovasc Surg.
2021 Apr;69(4):752-755. doi: 10.1007/s11748-020-01539-4.
-
Yamamoto H, Yamamoto H, Toyooka S. A New Scoring System for
Predicting the Survival of
Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
Ann Surg
Oncol. 2021 Jul;28(7):3891-3892. doi: 10.1245/s10434-020-09299-4.
-
Miura A, Shien K, Toji T, et al. A Giant Thymic Cyst
Accompanied by Acute Mediastinitis.
Acta Med Okayama. 2020 Oct;74(5):431-433. doi: 10.18926/AMO/60804.
-
Soh J, Sugimoto S, Namba K, et al. Chronic Lung Injury After
Trimodality Therapy for
Locally Advanced Non-Small Cell Lung Cancer. Ann Thorac Surg. 2021
Jul;112(1):279-288.
doi: 10.1016/j.athoracsur.2020.07.068.
-
Sato H, Offin M, Kubota D, et al. Allele-Specific Role of
ERBB2 in the Oncogenic
Function of EGFR L861Q in EGFR-Mutant Lung Cancers. J Thorac Oncol. 2021
Jan;16(1):113-126. doi: 10.1016/j.jtho.2020.09.019.
-
Hatono M, Ikeda H, Suzuki Y, et al. Effect of isoflavones on
breast cancer cell
development and their impact on breast cancer treatments. Breast Cancer Res
Treat. 2021
Jan;185(2):307-316. doi: 10.1007/s10549-020-05957-z. Epub 2020 Oct 9.
-
Yamamoto H, Sugimoto S, Miyoshi K, et al. Lung
transplantation for Kartagener syndrome:
technical aspects and morphological adaptation of the transplanted lungs.
Gen Thorac
Cardiovasc Surg. 2021 Mar;69(3):588-592. doi: 10.1007/s11748-020-01509-w.
-
Yamamoto H, Namba K, Yamamoto H, et al. The
neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple
metastatic lung tumors from various sarcomas.
Surg Today. 2021 Jan;51(1):127-135. doi: 10.1007/s00595-020-02093-5.
-
Taira N, Kashiwabara K, Tsurutani J, et al. Quality of life
in a randomized phase II
study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with
metastatic breast cancer. Breast Cancer. 2021 Sep 7:1–13. doi:
10.1007/s12282-021-01290-5.
-
Taira N, Sawaki M, Uemura Y, et al. Health-Related Quality of
Life With Trastuzumab
Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in
Older
Patients With HER2-Positive Breast Cancer. J Clin Oncol. 2021 Aug
1;39(22):2452-2462.
doi: 10.1200/JCO.20.02751.
-
Tsukioki T, Shien T, Ohtani Y, et al. Evaluation of Prognosis
of Juvenile Differentiated
Thyroid Carcinoma. Acta Med Okayama. 2020 Oct;74(5):401-406. doi:
10.18926/AMO/60799.
2020
-
Yamane M, Sugimoto S, Suzuki E, et al. Continuing surgical
education of non-technical
skills. Ann Med Surg (Lond). 2020 Aug 8;58:177-186. doi:
10.1016/j.amsu.2020.07.062.
-
Soh J, Suzawa K, Shien K, et al. Prognostic nutrition index
affects the prognosis of
patients undergoing trimodality therapy for locally advanced non-small cell lung
cancer.
Surg Today. 2020 Dec;50(12):1610-1618. doi: 10.1007/s00595-020-02067-7.
-
Shikatani Y, Soh J, Shien K, et al. Effectiveness of
scheduled intravenous acetaminophen
in the postoperative pain management of video-assisted thoracic surgery.
Surg Today.
2021 Apr;51(4):589-594. doi: 10.1007/s00595-020-02127-y.
-
Ochi K, Suzawa K, Tomida S, et al. Overcoming
epithelial-mesenchymal transition-mediated
drug resistance with monensin-based combined therapy in non-small cell lung
cancer.
Biochem Biophys Res Commun. 2020 Aug 27;529(3):760-765. doi: 10.1016/j.bbrc.2020.06.077.
-
Takahashi Y, Soh J, Shien K, et al. Fibrosis or Necrosis in
Resected Lymph Node Indicate
Metastasis Before Chemoradiotherapy in Lung Cancer Patients. Anticancer
Res. 2020
Aug;40(8):4419-4423. doi: 10.21873/anticanres.14447.
-
Yamamoto H, Sugimoto S, Kurosaki T, et al. Lung perfusion
scintigraphy to detect chronic
lung allograft dysfunction after living-donor lobar lung transplantation.
Sci Rep. 2020
Jun 29;10(1):10595. doi: 10.1038/s41598-020-67433-4.
-
Tsukioki T, Shien T, Tanaka T, et al. Influences of
preoperative metformin on
immunological factors in early breast cancer. Cancer Chemother Pharmacol.
2020
Jul;86(1):55-63. doi: 10.1007/s00280-020-04092-2.
-
Miyauchi S, Shien K, Takeda T, et al. Antitumor Effects of
Pan-RAF Inhibitor LY3009120
Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation. Anticancer
Res. 2020
May;40(5):2667-2673. doi: 10.21873/anticanres.14237.
-
Sato H, Schoenfeld AJ, Siau E, et al. MAPK Pathway
Alterations Correlate with Poor
Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by
ROS1
Fusions. Clin Cancer Res. 2020 Jun 15;26(12):2932-2945. doi:
10.1158/1078-0432.CCR-19-3321.
-
Yamane M, Mandai Y, Ino H, et al. A Surgical Instructor
Training Course for the Next
Generation. Acta Med Okayama. 2020 Feb;74(1):73-76. doi:
10.18926/AMO/57956.
-
Yamamoto H, Miyoshi K, Otani S, et al. Right single lung
transplantation using an
inverted left donor lung: interposition of pericardial conduit for pulmonary venous
anastomosis - a case report. BMC Pulm Med. 2020 Feb 19;20(1):46. doi:
10.1186/s12890-020-1075-4.
-
Sugimoto S, Soh J, Suzawa K, et al. Pulmonary aspergillosis
as a late complication after
surgery for locally advanced non-small cell lung cancer treated with induction
chemoradiotherapy. Surg Today. 2020 Aug;50(8):863-871. doi:
10.1007/s00595-020-01960-5.
-
Shien T, Iwata H. Adjuvant and neoadjuvant therapy for breast
cancer. Jpn J Clin Oncol.
2020 Mar 9;50(3):225-229. doi: 10.1093/jjco/hyz213.
2019
-
Takeda T, Yamamoto H, Suzawa K, et al.
YES1 activation induces acquired resistance to neratinib in
HER2-amplified breast and lung cancers.Cancer Sci. 2020 Mar;111(3):849-856.
doi: 10.1111/cas.14289.
-
Yoshioka T, Shien K, Takeda T, et al.
Acquired resistance mechanisms to afatinib in HER2-amplified
gastric cancer cells.Cancer Sci. 2019 Aug;110(8):2549-2557. doi:
10.1111/cas.14089.
-
Irie M, Otani S, Kurosaki T, et al.
Warm retrograde perfusion can remove more fat from lung
grafts with fat embolism in a porcine model.
Gen Thorac Cardiovasc Surg. 2020 Apr;68(4):363-369. doi: 10.1007/s11748-019-01245-w.
-
Nishiyama K, Taira N, Mizoo T, et al.
Influence of breast density on breast cancer risk: a case
control study in Japanese women.
Breast Cancer. 2020 Mar;27(2):277-283. doi: 10.1007/s12282-019-01018-6.
-
Sugimoto S, Kurosaki T, Otani S, et al.
Feasibility of lung transplantation from donors mechanically
ventilated for prolonged periods
Surg Today. 2019 Mar;49(3):254-260. doi: 10.1007/s00595-018-1730-z.
-
Tanaka S, Sugimoto S, Soh J, et al.
Long-term outcomes of pneumonectomy, back-table lung
preservation, double-sleeve resection and reimplantation for advanced central lung
cancer: the Oto procedure.
Eur J Cardiothorac Surg. 2019 Jul 1;56(1):213-214. doi: 10.1093/ejcts/ezy431.
-
Tanaka S, Miyoshi K, Higo H, et al.
Lung transplant candidates with idiopathic pulmonary fibrosis
and long-term pirfenidone therapy: Treatment feasibility influences waitlist
survival.
Respir Investig. 2019 Mar;57(2):165-171. doi: 10.1016/j.resinv.2018.12.002.
-
Mesaki K, Yamane M, Sugimoto S, et al.
SOCS3 overexpression in T cells ameliorates chronic airway
obstruction in a murine heterotopic tracheal transplantation model
Surg Today. 2019 May;49(5):443-450. doi: 10.1007/s00595-018-1753-5.
-
Taka H, Miyoshi K, Kurosaki T, et al.
Lung transplantation via cardiopulmonary bypass: excellent
survival outcomes from extended criteria donors
Gen Thorac Cardiovasc Surg. 2019 Jul;67(7):624-632. doi: 10.1007/s11748-019-01067-w.
-
Hirano Y, Sugimoto S, Yamamoto S, et al.
Prolonged warm ischemia exacerbated acute rejection after
lung transplantation from donation after cardiac death in a mouse
Gen Thorac Cardiovasc Surg. 2020 Jan;68(1):57-62. doi: 10.1007/s11748-019-01181-9.
-
Hashimoto K, Yamane M, Sugimoto S, et al.
Negative impact of recipient SPRED2 deficiency on
transplanted lung in a mouse model
Transpl Immunol. 2019 Dec;57:101242. doi: 10.1016/j.trim.2019.101242.
-
Suzawa K, Offin M, Lu D, et al.
Activation of KRAS Mediates Resistance to Targeted Therapy in
MET Exon 14-mutant Non-small Cell Lung Cancer
Clin Cancer Res. 2019 Feb 15;25(4):1248-1260. doi: 10.1158/1078-0432.CCR-18-1640.
-
Suzawa K, Soh J, Takahashi Y, et al.
Clinical outcome of patients with recurrent non-small cell
lung cancer after trimodality therapy
Surg Today. 2019 Jul;49(7):601-609. doi: 10.1007/s00595-019-1774-8.
-
Suzawa K, Offin M, Schoenfeld AJ, et al.
Acquired MET Exon 14 Alteration Drives Secondary Resistance
to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung
Cancer
JCO Precis Oncol. 2019;3:PO.19.00011. doi: 10.1200/PO.19.00011.
-
Miyauchi S, Shien K, Tanaka M, et al.
Pulmonary resection in a prone position for lung cancer
invading the spine
Gen Thorac Cardiovasc Surg. 2020 Mar;68(3):298-301. doi: 10.1007/s11748-019-01113-7.
-
Sato H, Soh J, Aoe K, et al.
Droplet digital PCR as a novel system for the detection of
microRNA‑34b/c methylation in circulating DNA in malignant pleural
mesothelioma.
Int J Oncol. 2019 Jun;54(6):2139-2148. doi: 10.3892/ijo.2019.4768.
-
Namba K, Shien K, Takahashi Y, et al.
Activation of AXL as a Preclinical Acquired Resistance
Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer
Cells.
Mol Cancer Res. 2019 Feb;17(2):499-507. doi: 10.1158/1541-7786.MCR-18-0628.
-
Namba K, Tomida S, Matsubara T, et al.
Application of amplicon-based targeted sequencing with the
molecular barcoding system to detect uncommon minor EGFR mutations in patients with
treatment-naïve lung adenocarcinoma.
BMC Cancer. 2019 Feb 26;19(1):175. doi: 10.1186/s12885-019-5374-1.
-
Konishi Y, Miyoshi K, Kurosaki T, et al.
Airway bacteria of the recipient but not the donor are
relevant to post-lung transplant pneumonia.
Gen Thorac Cardiovasc Surg. 2020 Aug;68(8):833-840. doi: 10.1007/s11748-019-01273-6.
-
Kurosaki T, Otani S, Miyoshi K, et al.
Favorable survival even with high disease-specific
complication rates in lymphangioleiomyomatosis after lung transplantation-long-term
follow-up of a Japanese center.
Clin Respir J. 2020 Feb;14(2):116-123. doi: 10.1111/crj.13108. Epub 2019 Nov 28.
-
Soh J, Toyooka S, Okumura N, et al.
Impact of pathological stage and histological subtype on
clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral
uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401
trial.
Int J Clin Oncol. 2019 Nov;24(11):1367-1376. doi: 10.1007/s10147-019-01508-9.
-
Kurihara E, Shien K, Torigoe H, et al.
Ganetespib in Epidermal Growth Factor Receptor-Tyrosine
Kinase Inhibitor-resistant Non-small Cell Lung Cancer.
Anticancer Res. 2019 Apr;39(4):1767-1775. doi: 10.21873/anticanres.13283.
-
Ogoshi Y, Shien K, Yoshioka T, et al.
Anti-tumor effect of neratinib against lung cancer cells
harboring HER2 oncogene alterations.
Oncol Lett. 2019 Mar;17(3):2729-2736. doi: 10.3892/ol.2019.9908.
-
Sugimoto S, Yamamoto H, Kurosaki T, et al.
Impact of chronic lung allograft dysfunction, especially
restrictive allograft syndrome, on the survival after living-donor lobar lung
transplantation compared with cadaveric lung transplantation in adults: a
single-center experience.
Surg Today. 2019 Aug;49(8):686-693. doi: 10.1007/s00595-019-01782-0.
2018
-
Yamamoto H, Yatabe Y, Toyooka S, et al.
Inherited lung cancer syndromes targeting never
smokers
Transl Lung Cancer Res. 2018 Aug;7(4):498-504. doi: 10.21037/tlcr.2018.06.01.
-
Yamamoto H, Toyooka S, Ninomiya T, et al.
Therapeutic Potential of Afatinib for Cancers
with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E
Oncologist. 2018 Feb;23(2):150-154. doi: 10.1634/theoncologist.2017-0345.
-
Yamamoto H, Sugimoto S, Tanaka S, et al.
A single-nucleotide polymorphism in a gene modulating
glucocorticoid sensitivity is associated with the decline in total lung capacity
after lung transplantation.
Surg Today. 2019 Mar;49(3):268-274. doi: 10.1007/s00595-018-1717-9.
-
Toyooka S, Okumura N, Nakamura H, et al.
A Multicenter Randomized Controlled Study of Paclitaxel plus
Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected
Non-Small Cell Lung Cancer.
J Thorac Oncol. 2018 May;13(5):699-706. doi: 10.1016/j.jtho.2018.02.015.
-
Sugimoto S, Miyoshi K, Kurosaki T, et al.
Favorable survival in lung transplant recipients on
preoperative low-dose, as compared to high-dose corticosteroids, after hematopoietic
stem cell transplantation
Int J Hematol. 2018 Jun;107(6):696-702. doi: 10.1007/s12185-018-2417-3.
-
Mesaki K, Sugimoto S, Otani S, et al.
Pneumatosis intestinalis after lung transplantation for
pulmonary graft-versus-host disease
J Thorac Dis. 2018 Jan;10(1):E42-E45. doi: 10.21037/jtd.2017.11.121.
-
Otani S, Kurosaki T, Sugimoto S, et al.
Unilateral lung transplantation using intact bilateral upper
lobes
J Thorac Cardiovasc Surg. 2018 Jul;156(1):e35-e38. doi: 10.1016/j.jtcvs.2018.03.003.
-
Sugimoto S, Yamane M, Otani S, et al.
Airway complications have a greater impact on the outcomes of
living-donor lobar lung transplantation recipients than cadaveric lung
transplantation recipients
Surg Today. 2018 Sep;48(9):848-855. doi: 10.1007/s00595-018-1663-6.
-
Kurosaki T, Miyoshi K, Otani S, et al.
Low-risk donor lungs optimize the post-lung transplant
outcome for high lung allocation score patients
Surg Today. 2018 Oct;48(10):928-935. doi: 10.1007/s00595-018-1670-7.
-
Okada M, Yamane M, Yamamoto S, et al.
SPRED2 deficiency may lead to lung ischemia-reperfusion
injury via ERK1/2 signaling pathway activation
Surg Today. 2018 Dec;48(12):1089-1095. doi: 10.1007/s00595-018-1696-x.
-
Habu T, Soh J, Toji T, et al.
Myoepithelioma occurring in the posterior mediastinum
harboring EWSR1 rearrangement: a case report
Jpn J Clin Oncol. 2018 Sep 1;48(9):851-854. doi: 10.1093/jjco/hyy100.
-
Tanaka S, Sugimoto S, Kurosaki T, et al.
Donor-derived cell-free DNA is associated with acute
rejection and decreased oxygenation in primary graft dysfunction after living
donor-lobar lung transplantation
Sci Rep. 2018 Oct 18;8(1):15366. doi: 10.1038/s41598-018-33848-3.
-
Sugimoto S, Kurosaki T, Otani S, et al.
Feasibility of lung transplantation from donors mechanically
ventilated for prolonged periods
Surg Today. 2019 Mar;49(3):254-260. doi: 10.1007/s00595-018-1730-z.
-
Sugimoto S
Can pretransplant computed-tomographic assessment predict
outcomes after lung transplantation?
J Thorac Dis. 2018 Oct;10(10):5652-5654. doi: 10.21037/jtd.2018.09.51.
-
Takahashi Y, Shien K, Tomida S, et al.
Comparative mutational evaluation of multiple lung cancers by
multiplex oncogene mutation analysis.
Cancer Sci. 2018 Nov;109(11):3634-3642. doi: 10.1111/cas.13797.
-
Sato H, Yamamoto H, Sakaguchi M, et al.
Combined inhibition of MEK and PI3K pathways overcomes
acquired resistance to EGFR-TKIs in non-small cell lung cancer.
Cancer Sci. 2018 Oct;109(10):3183-3196. doi: 10.1111/cas.13763.
-
Sato H, Soh J, Hotta K, et al.
Is Surgery after Chemoradiotherapy Feasible in Lung Cancer
Patients with Superior Vena Cava Invasion?
Ann Thorac Cardiovasc Surg. 2018 Jun 20;24(3):131-138. doi: 10.5761/atcs.oa.18-00027.
-
Torigoe H, Yamamoto H, Sakaguchi M, et al.
Tumor-suppressive effect of LRIG1, a negative regulator of
ErbB, in non-small cell lung cancer harboring mutant EGFR.
Carcinogenesis. 2018 May 3;39(5):719-727. doi: 10.1093/carcin/bgy044.
-
Torigoe H, Shien K, Takeda T, et al.
Therapeutic strategies for afatinib-resistant lung cancer
harboring HER2 alterations.
Cancer Sci. 2018 May;109(5):1493-1502. doi: 10.1111/cas.13571.
-
Yoshioka T, Shien K, Namba K, et al.
Antitumor activity of pan-HER inhibitors in HER2-positive
gastric cancer.
Cancer Sci. 2018 Apr;109(4):1166-1176. doi: 10.1111/cas.13546.
-
Sato H, Sakaguchi M, Yamamoto H, et al.
Therapeutic potential of targeting S100A11 in malignant
pleural mesothelioma.
Oncogenesis. 2018 Jan 24;7(1):11. doi: 10.1038/s41389-017-0017-3.
-
Miura A, Mori T, Yoshida A, et al.
Primary adenocarcinoma of the trachea revealing a mucinous
bronchial gland cell origin.
Pathol Res Pract. 2018 May;214(5):796-799. doi: 10.1016/j.prp.2018.03.006.
-
Tanaka S, Miyoshi K, Higo H, et al.
Lung transplant candidates with idiopathic pulmonary fibrosis
and long-term pirfenidone therapy: Treatment feasibility influences waitlist
survival.
Respir Investig. 2019 Mar;57(2):165-171. doi: 10.1016/j.resinv.2018.12.002.
-
Shien T, Doihara H, Sato N, et al.
Serum lipid and bone metabolism effects of Toremifene vs.
Letrozole as adjuvant therapy for postmenopausal early breast cancer patients:
results of a multicenter open randomized study.
Cancer Chemother Pharmacol. 2018 Feb;81(2):269-275. doi: 10.1007/s00280-017-3491-6
-
Sasada S, Shien T, Iwata H, et al.
Current status of postmastectomy radiation therapy in T1-2
breast cancer with limited positive lymph nodes in Japan: Japan Clinical Oncology
Group Survey.
Breast Cancer. 2018 Sep;25(5):626-627. doi: 10.1007/s12282-018-0855-7.
-
Takahashi Y, Shien T, Sakamoto A, et al.
Current Multidisciplinary Approach to Fertility Preservation
for Breast Cancer Patients.
Acta Med Okayama. 2018 Apr;72(2):137-142. doi: 10.18926/AMO/55854.
-
Oka K, Shien T, Otsuka F, et al.
Thyroid follicular carcinoma in a teenager: A case
report.
J Gen Fam Med. 2018 Jun 21;19(5):170-172. doi: 10.1002/jgf2.185.
-
Oka K, Yasuda M, Shien T, et al.
A marked goiter involved in Marine-Lenhart syndrome.
J Gen Fam Med. 2018 Nov 24;20(1):37-38. doi: 10.1002/jgf2.220.
-
Shien T
The eligibility of primary tumor resection for de novo stage
IV breast cancer patients
Transl Cancer Res 2018;7(Suppl 5):S604-S607. doi: 10.21037/tcr.2018.05.28
-
Iwamoto T, Taira N, Fujisawa T, et al.
Hormonal Therapy Resistant Estrogen-receptor Positive
Metastatic Breast Cancer Cohort (HORSE-BC) Study : Current Status of Treatment
Selection in Japan
Acta Med Okayama. 2018 Aug;72(4):369-374. doi: 10.18926/AMO/56172.
2017
-
Sugimoto S, Yamane M, Miyoshi K, et al.
Pulmonary artery patch for an inadequate donor atrial cuff in
the absence of donor pericardium in lung transplantation
Surg Today. 2017 Mar;47(3):399-401. doi: 10.1007/s00595-016-1370-0.
-
Maki Y, Toyooka S, Soh J, et al.
Early postoperative complications after middle
lobe-preserving surgery for secondary lung cancer
Surg Today. 2017 May;47(5):601-605. doi: 10.1007/s00595-016-1413-6.
-
Okada M, Sugimoto S, Yamane M, et al.
Immunoglobulin G4-related disease presenting as an
intrapericardial tumor
Jpn J Clin Oncol. 2017 Jan;47(1):88-89. doi: 10.1093/jjco/hyw161
-
Sugimoto S, Otani S, Ohki T, et al.
Lung retransplantation in an adult 13 years after single
lobar transplant in childhood
Gen Thorac Cardiovasc Surg. 2017 Sep;65(9):539-541. doi: 10.1007/s11748-016-0732-2.
-
Hashimoto K, Miyoshi K, Mizutani H, et al.
Successful Lung Transplantation for Pulmonary Disease
Associated With Erdheim-Chester Disease
Ann Thorac Surg. 2017 Jul;104(1):e13-e15. doi: 10.1016/j.athoracsur.2017.02.020.
-
Kawana S, Yamamoto H, Maki Y, et al.
Reconstruction of Anterior Chest Wall with Polypropylene
Mesh: Two Primary Sternal Chondrosarcoma Cases
Acta Med Okayama. 2017 Jun;71(3):259-262. doi: 10.18926/AMO/55210.
-
Tanaka S, Miyoshi K, Sugimoto S, et al.
Successful Lung Transplantation Using a Deceased Donor
Mechanically Ventilated for Ten Months
Ann Thorac Surg. 2017 Aug;104(2):e177-e179. doi: 10.1016/j.athoracsur.2017.03.019.
-
Hirano Y, Sugimoto S, Mano T, et al.
Prolonged Administration of Twice-Daily Bolus Intravenous
Tacrolimus in the Early Phase After Lung Transplantation
Ann Transplant. 2017 Aug 11;22:484-492. doi: 10.12659/aot.904225.
-
Yamamoto H, Sugimoto S, Otani S, et al.
Postoperative pyoderma gangrenosum exacerbated by
granulocyte-colony stimulating factor after lung cancer surgery
Jpn J Clin Oncol. 2017 Oct 1;47(10):991-992. doi: 10.1093/jjco/hyx121.
-
Shien K, Papadimitrakopoulou VA, Ruder D, et al.
JAK1/STAT3 Activation through a Proinflammatory Cytokine
Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung
Cancer
Mol Cancer Ther. 2017 Oct;16(10):2234-2245. doi: 10.1158/1535-7163.MCT-17-0148.
-
Shien K, Toyooka S, Soh J, et al.
Is tumor location an independent prognostic factor in locally
advanced non-small cell lung cancer treated with trimodality therapy?
J Thorac Dis. 2017 May;9(5):E489-E491. doi: 10.21037/jtd.2017.03.183.
-
Chen H, Shien K, Suzawa K, et al.
Elacridar, a third-generation ABCB1 inhibitor, overcomes
resistance to docetaxel in non-small cell lung cancer
Oncol Lett. 2017 Oct;14(4):4349-4354. doi: 10.3892/ol.2017.6678.
-
Takeda T, Yamamoto H, Kanzaki H, et al.
Yes1 signaling mediates the resistance to Trastuzumab/Lap
atinib in breast cancer
PLoS One. 2017 Feb 3;12(2):e0171356. doi: 10.1371/journal.pone.0171356.
-
Iwamoto T, Katagiri T, Niikura N, et al.
Immunohistochemical Ki67 after short-term hormone therapy
identifies low-risk breast cancers as reliably as genomic markers
Oncotarget. 2017 Apr 18;8(16):26122-26128. doi: 10.18632/oncotarget.15385.
-
Kochi M, Iwamoto T, Niikura N, et al.
Tumour-infiltrating lymphocytes (TILs)-related genomic
signature predicts chemotherapy response in breast cancer
Breast Cancer Res Treat. 2018 Jan;167(1):39-47. doi: 10.1007/s10549-017-4502-3.
-
Shien T, Iwata H
Significance of primary lesion resection in Stage IV breast
cancer
Jpn J Clin Oncol. 2017 May 1;47(5):381-384. doi: 10.1093/jjco/hyx027.
-
Shien T, Tanaka T, Tanabe M, et al.
Evaluation of ALDH1 expression in ipsilateral breast cancer
recurrence
Oncol Lett. 2017 Mar;13(3):1071-1077. doi: 10.3892/ol.2016.5538.
-
Saiga M, Taira N, Kimata Y, et al.
Development of a Japanese version of the BREAST-Q and the
traditional psychometric test of the mastectomy module for the assessment of HRQOL
and patient satisfaction following breast surgery
Breast Cancer. 2017 Mar;24(2):288-298. doi: 10.1007/s12282-016-0703-6.
-
Hara A, Taira N, Mizoo T, et al.
N-acetyltransferase 2 polymorphism and breast cancer risk
with smoking: a case control study in Japanese women
Breast Cancer. 2017 Mar;24(2):254-262. doi: 10.1007/s12282-016-0696-1.
2016
-
Soh J, Toyooka S, Matsuo K, et al.
Ethnicity affects EGFR and KRAS gene alterations of lung
adenocarcinoma
Oncol Lett. 2015 Sep;10(3):1775-1782. doi: 10.3892/ol.2015.3414.
-
Soh J, Okumura N, Nakata M, et al.
Randomized feasibility study of S-1 for adjuvant chemotherapy
in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi
Lung Cancer Group Study 0701
Jpn J Clin Oncol. 2016 Aug;46(8):741-7. doi: 10.1093/jjco/hyw062.
-
Sugimoto S, Miyoshi K, Yamane M, et al.
Lung transplantation for diffuse panbronchiolitis: 5 cases
from a single centre
Interact Cardiovasc Thorac Surg. 2016 May;22(5):679-81. doi: 10.1093/icvts/ivw008.
-
Suzawa K, Toyooka S, Sakaguchi M, et al.
Antitumor effect of afatinib, as a human epidermal growth
factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene
alterations
Cancer Sci. 2016 Jan;107(1):45-52. doi: 10.1111/cas.12845.
-
Suzawa K, Yamamoto H, Murakami T, et al.
Establishment and molecular characterization of cell lines
from Japanese patients with malignant pleural mesothelioma
Oncol Lett. 2016 Jan;11(1):705-712. doi: 10.3892/ol.2015.3955.
-
Shien K, Toyooka S, Soh J, et al.
Clinicopathological characteristics and lymph node metastasis
pathway of non-small-cell lung cancer located in the left lingular division
Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):791-6. doi: 10.1093/icvts/ivv062.
-
Watanabe M, Yamamoto H, Hashida S, et al.
Primary pulmonary melanoma: a report of two cases
World J Surg Oncol. 2015 Sep 17;13:274. doi: 10.1186/s12957-015-0695-2.
-
Watanabe M, Yamamoto H, Eikawa S, et al.
Study about the Efficacy of Metformin to Immune Function in
Cancer Patients
Acta Med Okayama. 2016 Aug;70(4):327-30. doi: 10.18926/AMO/54514.
-
Taira N, Arai M, Ito Y, et al.
The Japanese Breast Cancer Society clinical practice
guidelines for epidemiology and prevention of breast cancer, 2015 edition
Breast Cancer. 2016 May;23(3):343-56. doi: 10.1007/s12282-016-0673-8.
-
Taira N, Fujisawa T, Araki K, et al.
Cohort Study of Secondary Endocrine Therapy in Metastatic
Breast Cancer with a Poor Response to Initial Endocrine Therapy
J Clin Trials 6,2016
-
Ito M, Shien T, Kaji M, et al.
Correlation between 18F-fluorodeoxyglucose Positron Emission
Tomography/computed Tomography and Clinicopathological Features in Invasive Ductal
Carcinoma of the Breast
Acta Med Okayama. 2015;69(6):333-8. doi: 10.18926/AMO/53907.
-
Ito M, Shien T, Omori M, et al.
Evaluation of aldehyde dehydrogenase 1 and transcription
factors in both primary breast cancer and axillary lymph node metastases as a
prognostic factor
Breast Cancer. 2016 May;23(3):437-44. doi: 10.1007/s12282-015-0583-1.
-
Iwamoto T, Kumamaru H, Miyata H, et al.
Distinct breast cancer characteristics between screen- and
self-detected breast cancers recorded in the Japanese Breast Cancer
Registry
Breast Cancer Res Treat. 2016 Apr;156(3):485-494. doi: 10.1007/s10549-016-3770-7.
-
Iwamoto T, Kelly C, Mizoo T, et al.
Relative Prognostic and Predictive Value of Gene Signature
and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast
Cancer
Clin Breast Cancer. 2016 Apr;16(2):95-100.e1. doi: 10.1016/j.clbc.2015.10.004.
-
Miyoshi Y, Shien T, Ogiya A, et al.
Differences in expression of the cancer stem cell marker
aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth
factor receptor type 2-negative breast cancer cases with early, late, and no
recurrence
Breast Cancer Res. 2016 Jul 2;18(1):73. doi: 10.1186/s13058-016-0731-3.
-
Kimura K, Nakayama M, Naito I, et al.
Human collagen XV is a prominent histopathological component
of sinusoidal capillarization in hepatocellular carcinogenesis
Int J Clin Oncol. 2016 Apr;21(2):302-309. doi: 10.1007/s10147-015-0888-2
2015
-
Miyoshi S, Shien K, Toyooka S, et al.
Validity of using lobe-specific regional lymph node stations
to assist navigation during lymph node dissection in early stage non-small cell lung
cancer patients
Surg Today. 2014 Nov;44(11):2028-36. doi: 10.1007/s00595-013-0772-5.
-
Tao H, Shien K, Soh J, et al.
Density of tumor-infiltrating FOXP3+ T cells as a response
marker for induction chemoradiotherapy and a potential prognostic factor in patients
treated with trimodality therapy for locally advanced non-small cell lung
cancer
Ann Thorac Cardiovasc Surg. 2014;20(6):980-6. doi: 10.5761/atcs.oa.13-00237.
-
Oto T, Miyoshi K, Sugimoto S, et al.
Living related donor middle lobe lung transplant in a
pediatric patient
J Thorac Cardiovasc Surg. 2015 Mar;149(3):e42-4. doi: 10.1016/j.jtcvs.2014.10.102.
-
Toyooka S, Soh J, Yamamoto H, et al.
Extended sleeve lobectomy after induction chemoradiotherapy
for non-small cell lung cancer
Surg Today. 2015 Sep;45(9):1121-6. doi: 10.1007/s00595-014-1025-y.
-
Sugimoto S, Toyooka S, Suzawa K, et al.
Thoracoscopic lobectomy as salvage surgery for local
recurrence of non-small cell lung cancer after carbon ion radiotherapy in an
initially operable patient
Ann Thorac Cardiovasc Surg. 2014;20 Suppl:501-4. doi: 10.5761/atcs.cr.13-00223.
-
Sugimoto S, Oto T, Toyooka S, et al.
Kissing-stents technique after living-donor lobar lung
transplantation
Eur J Cardiothorac Surg. 2015 Jun;47(6):1105-6. doi: 10.1093/ejcts/ezu314.
-
Sugimoto S, Tanaka M, Suzawa K, et al.
Pneumocephalus and chylothorax complicating vertebrectomy for
lung cancer
Ann Thorac Surg. 2015 Apr;99(4):1425-8. doi: 10.1016/j.athoracsur.2014.05.098.
-
Otani H, Yamamoto H, Takaoka M, et al.
TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the
EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant
Non-Small Cell Lung Cancer Cells
PLoS One. 2015 Jun 19;10(6):e0129838. doi: 10.1371/journal.pone.0129838.
-
Yamamoto H, Soh J, Ichimura K, et al.
Adult mesenchymal hamartoma of the chest wall: report of a
case
Ann Thorac Cardiovasc Surg. 2014;20 Suppl:663-5. doi: 10.5761/atcs.cr.13-00225.
-
Otani S, Levvey BJ, Westall GP, et al.
Long-term successful outcomes from kidney transplantation
after lung and heart-lung transplantation
Ann Thorac Surg. 2015 Mar;99(3):1032-8. doi: 10.1016/j.athoracsur.2014.11.023.
-
Otani S, Westall GP, Levvey BJ, et al.
Managing central venous obstruction in cystic fibrosis
recipients--lung transplant considerations
J Cyst Fibros. 2015 Mar;14(2):255-61. doi: 10.1016/j.jcf.2014.08.003.
-
Miyoshi K, Oto T, Konishi Y, et al.
Use of Extended-Criteria Lungs on a Lobe-by-Lobe Basis
Through Ex Vivo Lung Perfusion Assessment
Ann Thorac Surg. 2015;99(5):1819-21. doi: 10.1016/j.athoracsur.2014.06.115.
-
Shien K, Toyooka S, Soh J, et al.
Lower lobe origin is a poor prognostic factor in locally
advanced non-small-cell lung cancer patients treated with induction
chemoradiotherapy
Mol Clin Oncol. 2015 May;3(3):706-712. doi: 10.3892/mco.2015.509.
-
Maki Y, Fujimoto J, Lang W, et al.
LAPTM4B is associated with poor prognosis in NSCLC and
promotes the NRF2-mediated stress response pathway in lung cancer cells
Sci Rep. 2015 Sep 7;5:13846. doi: 10.1038/srep13846.
-
Taira N, Arai M, Ikeda M, et al.
The Japanese Breast Cancer Society clinical practice
guideline for epidemiology and prevention of breast cancer
Breast Cancer. 2015 Jan;22(1):16-27. doi: 10.1007/s12282-014-0555-x.
-
Taira N, Akiyama I, Ishihara S, et al.
Impact of modifiable lifestyle factors on outcomes after
breast cancer diagnosis: the Setouchi Breast Cancer Cohort Study
Jpn J Clin Oncol. 2015 Jun;45(6):600-2. doi: 10.1093/jjco/hyv033.
-
Nogami T, Taira N, Toyooka S, et al.
A case of carcinoma showing thymus-like differentiation with
a rapidly lethal course
Case Rep Oncol. 2014 Dec 20;7(3):840-4. doi: 10.1159/000370306.
-
Itoh M, Iwamoto T, Matsuoka J, et al.
Estrogen receptor (ER) mRNA expression and molecular subtype
distribution in ER-negative/progesterone receptor-positive breast cancers
Breast Cancer Res Treat. 2014 Jan;143(2):403-9. doi: 10.1007/s10549-013-2763-z.
学会事務局
呼吸器・乳腺内分泌外科が事務局となっている学会の最新情報をお知らせいたします。
詳しくはこちら
お問い合わせ
肺移植に関するご相談、呼吸器・乳腺内分泌外科医局への入局ご希望の方など、お気軽にお問い合わせくださいませ。
詳しくはこちら